Aurobindo Pharma Limited tumbles 7% on muted Q4

Aurobindo Pharma Limited tumbles 7% on muted Q4

Tuesday, May 29, 2018


aurobindo_pharma
Aurobindo Pharma fell as much as 7.45% on early Tuesday on muted quarterly numbers. The drug firm on Monday reported a marginal decline in its net profit at Rs 528.5 crore for the fourth quarter to March 2018.
Its net profit read Rs 532.5 crore in the previous fiscal. Revenue from operations, however, rose to Rs 4,049.1 crore for January-March, compared with Rs 3,641.6 crore earlier, Aurobindo Pharma said in a regulatory filing.

For more information on commodity tips

and quick free trial click here > 911 133 9000

Visit http://www.epicresearch.co

Connect with our social media sites
Next
« Prev Post
Previous
Next Post »